You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Osteosarcopenia in rheumatoid arthritis treated with glucocorticosteroids – essence, significance, consequences
Contributor:
Radkowski, Marcin;
Sławiński, Piotr;
Targowski, Tomasz
Published:
Termedia Sp. z.o.o., 2020
Published in:
Rheumatology, 58 (2020) 2, Seite 101-106
Language:
Not determined
DOI:
10.5114/reum.2020.95364
ISSN:
0034-6233;
2084-9834
Origination:
Footnote:
Description:
Rheumatoid arthritis (RA) is one of the most common rheumatic diseases, associated with cooccurrence of serious side effects. This study discusses the problems associated with chronic RA, well-known as osteoporosis, but also recently recognized as sarcopenia. Relationships between sarcopenia and rheumatic diseases are not yet fully understood. Co-occurrence of osteoporosis and sarcopenia, referred to as osteosarcopenia, is becoming increasingly important. The overlap of the effects of RA and osteosarcopenia and the adverse effects of glucocorticosteroids leads to progressive impairment of the musculoskeletal system, increasing the risk of falls, fractures, institutionalization and death, and it is a source of dramatic socioeconomic burden on society. Very limited options for effective treatment of developed osteosarcopenia, as well as the severity of complications caused by it, advocates for the need of broad education and raising public awareness, especially among health care workers, in order to implement the prevention of osteosarcopenia as early as possible.